Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting enzymes involved in inflammatory diseases and cancer. Shows potential in developing selective inhibitors for protein kinases due to its structural similarity to purine-based signaling molecules. Also explored in the design of neuroprotective agents and modulators of central nervous system receptors. Its scaffold is valued for enhancing metabolic stability and binding affinity in drug candidates.